Czapska, Mirella, et al. “Sotagliflozin, an Inhibitor of sodium–glucose Cotransporters 1 and 2 (SGLT1 2), As a New Therapeutic Approach for Patients With Type 1 Diabetes Mellitus”. Journal of Education, Health and Sport, vol. 8, no. 12, Dec. 2018, pp. 335-51, https://apcz.umk.pl/JEHS/article/view/6378.